Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Aug;40(8):1343-1345.
doi: 10.1007/s00296-020-04624-2. Epub 2020 Jun 12.

Targeting the immunology of coronavirus disease-19: synchronization creates symphony

Sakir Ahmed  1 , Prajna Anirvan  2
Affiliations
Comment

Targeting the immunology of coronavirus disease-19: synchronization creates symphony

Sakir Ahmed et al. Rheumatol Int. 2020 Aug.
No abstract available

Keywords: Anticoagulation; COVID-19; Immune therapy; Strategy.

PubMed Disclaimer

Conflict of interest statement

Sakir Ahmed declares that he has no conflict of interest. Prajna Anirban declares that he has no conflict of interest.

Figures

Fig. 1
Fig. 1
Various hallmarks of Coronavirus disease 2019 (COVID-19) and multimodal strategies required to combat it. ARDS Acute Respiratory Distress Syndrome, AKI acute kidney injury, DIC disseminated intra-vascular coagulation, RAAS renin–angiotensin–aldosterone system, IvIg intravenous Immunoglobulin, CAR-T cells chimeric antigen receptor-T cells
See this image and copyright information in PMC

Comment on

References

    1. Stebbing J, Phelan A, Griffin I, et al. COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis. 2020;20:400–402. doi: 10.1016/S1473-3099(20)30132-8. - DOI - PMC - PubMed
    1. Gasparyan AY, Misra DP, Yessirkepov M, Zimba O. Perspectives of Immune Therapy in Coronavirus Disease 2019. J Korean Med Sci. 2020;35:e176. doi: 10.3346/jkms.2020.35.e176. - DOI - PMC - PubMed
    1. Misra DP, Agarwal V, Gasparyan AY, Zimba O. Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets. Clin Rheumatol. 2020 doi: 10.1007/s10067-020-05073-9. - DOI - PMC - PubMed
    1. Klok FA, Kruip MJHA, van der Meer NJM, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res. 2020 doi: 10.1016/j.thromres.2020.04.041. - DOI - PMC - PubMed
    1. Kernan KF, Canna SW. Should COVID-19 take advice from rheumatologists? Lancet Rheumatol. 2020 doi: 10.1016/S2665-9913(20)30129-6. - DOI - PMC - PubMed

LinkOut - more resources